AIWall Street Journalabout 4 hours ago
Johnson & Johnson CEO on Cancer, AI, Medical Innovation
1 min read
Johnson & Johnson CEO Joaquin Duato discussed the company's efforts in fighting cancer, leveraging artificial intelligence, and advancing medical innovation. Duato outlined the firm's strategic focus on these areas to drive future growth and improve patient outcomes. The interview covered the intersection of technology and healthcare within Johnson & Johnson's pipeline.
Level
Hype check
Tap to vote and see what everyone thinks.
